inflammatory bowel disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eligible patients were 18 years or older with active UC defined as a Mayo Clinic score16 4 with an endoscopic Mayo Clinic score 1. Concomitant treatments for UC, such as mesalamine, glucocorticoids, immunosuppressive therapy (eg,azathioprine), or tumor necrosis factor antagonists were permitted, provided these had been used at a stable dose for at least 12 weeks (4 weeks for glucocorticoids) and disease remained active.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had taken antibiotics or probiotics in the last 30 days, had concomitant C difficile infection or another enteric pathogen, had a disease severity that required hospitalization, were pregnant, or were unable to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mayo score;Endoscopic Mayo score; | — |
Countries
China
Contacts
Shanghai Renji Hospital